1. Miyazaki, Yuri, Otsuka, Takeshi, Yamagata, Yoko, Fukata, Yuko, Fukata, Masaki. 2024. Oligodendrocyte-derived LGI3 and its receptor ADAM23 organize juxtaparanodal Kv1 channel clustering for short-term synaptic plasticity. In Cell reports, 43, 113634. doi:10.1016/j.celrep.2023.113634. https://pubmed.ncbi.nlm.nih.gov/38194969/
2. Lee, Sang Eun, Lee, A-Young, Park, Woo-Jae, Kim, Yang-Gyun, Yun, Hye-Young. 2006. Mouse LGI3 gene: expression in brain and promoter analysis. In Gene, 372, 8-17. doi:. https://pubmed.ncbi.nlm.nih.gov/16545924/
3. Kim, Hyun A, Kwon, Nyoun Soo, Baek, Kwang Jin, Kim, Dong-Seok, Yun, Hye-Young. 2015. Leucine-rich glioma inactivated 3 and tumor necrosis factor-α regulate mutually through NF-κB. In Cytokine, 72, 220-3. doi:10.1016/j.cyto.2014.12.023. https://pubmed.ncbi.nlm.nih.gov/25648289/
4. Kim, In Wook, Jeong, Hyo-Soon, Kwon, Nyoun Soo, Yun, Hye-Young, Kim, Dong-Seok. 2018. LGI3 promotes human keratinocyte differentiation via the Akt pathway. In Experimental dermatology, 27, 1224-1229. doi:10.1111/exd.13766. https://pubmed.ncbi.nlm.nih.gov/30091803/
5. Lee, Seung Hoon, Kwon, Nyoun Soo, Baek, Kwang Jin, Yun, Hye-Young, Kim, Dong-Seok. 2019. LGI3 is secreted and binds to ADAM22 via TRIF-dependent NF-κB pathway in response to LPS in human keratinocytes. In Cytokine, 126, 154872. doi:10.1016/j.cyto.2019.154872. https://pubmed.ncbi.nlm.nih.gov/31627033/
6. Kwon, Nyoun Soo, Kim, Dong-Seok, Yun, Hye-Young. 2017. Leucine-rich glioma inactivated 3: integrative analyses support its prognostic role in glioma. In OncoTargets and therapy, 10, 2721-2728. doi:10.2147/OTT.S138912. https://pubmed.ncbi.nlm.nih.gov/28579810/
7. Kim, Hyun A, Park, Woo-Jae, Jeong, Hyo-Soon, Kim, Dong-Seok, Yun, Hye-Young. 2012. Leucine-rich glioma inactivated 3 regulates adipogenesis through ADAM23. In Biochimica et biophysica acta, 1821, 914-22. doi:10.1016/j.bbalip.2012.02.010. https://pubmed.ncbi.nlm.nih.gov/22405860/
8. Yun, Hye-Young. . Leucine rich repeat LGI family member 3: Integrative analyses support its prognostic association with pancreatic adenocarcinoma. In Medicine, 103, e37183. doi:10.1097/MD.0000000000037183. https://pubmed.ncbi.nlm.nih.gov/38394487/